secwatch.observer — SEC 8-K summary
======================================

Issuer:     Turning Point Brands, Inc. (TPB)
CIK:        0001290677
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001437749-25-024957
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Turning Point Brands Q2 net sales up 25% to $116.6M; Modern Oral surges 651%; raises guidance
--------------------------------------------------------------------------------

- Net sales $116.6M (+25.1% YoY); net income $14.5M (+11.3%); diluted EPS $0.79.
- Modern Oral sales $30.1M (+651% YoY), now 26% of total sales; Stoker's segment up 62.9%.
- Adjusted EBITDA $30.5M (+14.8%); adjusted diluted EPS $0.98 vs $0.89 prior year.
- Raises 2025 Adj. EBITDA guidance to $110-114M (from $108-113M).
- Raises 2025 Modern Oral sales guidance to $100-110M (from $80-95M).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1290677/000143774925024957/0001437749-25-024957-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1290677/000143774925024957/tpb20250728_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-024957

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer